Studies on the pharmacological control of hyperlipemia in experimental nephrotic syndrome
- 31 October 1970
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 19 (10) , 2719-2725
- https://doi.org/10.1016/0006-2952(70)90098-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The effects of p-chlorophenoxyisobutyrate on the turnover rate and distribution of thyroid hormone in the ratBiochemical Pharmacology, 1969
- The role of the thyroid hormone in the effect of p-chlorophenoxyisobutyrate in ratsBiochemical Pharmacology, 1968
- Changes in the liver concentrations of the nicotinamide adenine dinucleotide coenzymes and in the activities of oxidoreductase enzymes following treatment of the rat with ethyl chlorophenoxyisobutyrate (Atromid-S)Biochemical Pharmacology, 1966
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965
- The effect of a single intravenous injection of aminonucleoside of Puromycin on the rat kidney: A light‐ and electron‐microscope studyThe Journal of Pathology and Bacteriology, 1962
- STUDIES ON THE SYNTHESIS AND SECRETION OF SERUM LIPOPROTEINS BY RAT LIVER SLICESJournal of Clinical Investigation, 1960
- MECHANISMS OF HYPERLIPEMIA IN EXPERIMENTAL NEPHROSIS*Journal of Clinical Investigation, 1959
- THE MEASUREMENT OF CREATININE IN PLASMA AND URINEImmunology & Cell Biology, 1958
- Plasma Lipid Interrelationships in Experimental Nephrosis1Journal of Clinical Investigation, 1957
- Zur Frage der LipoidnephroseVirchows Archiv, 1926